Yasutomo Nasu

7.5k total citations
295 papers, 5.4k citations indexed

About

Yasutomo Nasu is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Yasutomo Nasu has authored 295 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Pulmonary and Respiratory Medicine, 88 papers in Surgery and 84 papers in Molecular Biology. Recurrent topics in Yasutomo Nasu's work include Bladder and Urothelial Cancer Treatments (49 papers), Prostate Cancer Treatment and Research (43 papers) and Prostate Cancer Diagnosis and Treatment (39 papers). Yasutomo Nasu is often cited by papers focused on Bladder and Urothelial Cancer Treatments (49 papers), Prostate Cancer Treatment and Research (43 papers) and Prostate Cancer Diagnosis and Treatment (39 papers). Yasutomo Nasu collaborates with scholars based in Japan, United States and China. Yasutomo Nasu's co-authors include Hiromi Kumon, Masami Watanabe, Takashi Saika, Tomoyasu Tsushima, Timothy C. Thompson, Shin Ebara, Guang Yang, Masakiyo Sakaguchi, Motoo Araki and Chris H. Bangma and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Nature Medicine.

In The Last Decade

Yasutomo Nasu

282 papers receiving 5.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yasutomo Nasu Japan 39 2.3k 1.3k 1.1k 1.1k 786 295 5.4k
Joseph E. Italiano United States 50 2.9k 1.2× 1.6k 1.2× 1.6k 1.4× 876 0.8× 378 0.5× 133 9.7k
Ricardo D. Coletta Brazil 51 3.8k 1.6× 751 0.6× 1.9k 1.8× 1.2k 1.1× 961 1.2× 319 8.0k
Bernd Wullich Germany 41 2.3k 1.0× 1.5k 1.2× 1.0k 0.9× 1.3k 1.2× 346 0.4× 297 5.5k
Jiří Bártek Denmark 41 2.2k 1.0× 671 0.5× 2.0k 1.8× 957 0.9× 544 0.7× 168 6.4k
Jerry Ware United States 50 2.0k 0.8× 1.1k 0.8× 1.0k 1.0× 1.1k 1.0× 800 1.0× 148 8.4k
Márcio F. Chedid Brazil 36 2.5k 1.0× 475 0.4× 1.2k 1.1× 726 0.7× 316 0.4× 112 4.8k
Henrik Alfthan Finland 42 1.5k 0.6× 1.1k 0.9× 803 0.7× 779 0.7× 583 0.7× 135 5.7k
Dietrich von Schweinitz Germany 46 3.2k 1.4× 754 0.6× 1.5k 1.4× 1.8k 1.6× 596 0.8× 189 6.8k
Arinobu Tojo Japan 45 3.1k 1.3× 717 0.6× 1.9k 1.8× 816 0.8× 515 0.7× 364 8.2k
Fabien Calvo France 45 3.3k 1.4× 606 0.5× 2.3k 2.1× 534 0.5× 719 0.9× 160 6.7k

Countries citing papers authored by Yasutomo Nasu

Since Specialization
Citations

This map shows the geographic impact of Yasutomo Nasu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasutomo Nasu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasutomo Nasu more than expected).

Fields of papers citing papers by Yasutomo Nasu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasutomo Nasu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasutomo Nasu. The network helps show where Yasutomo Nasu may publish in the future.

Co-authorship network of co-authors of Yasutomo Nasu

This figure shows the co-authorship network connecting the top 25 collaborators of Yasutomo Nasu. A scholar is included among the top collaborators of Yasutomo Nasu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasutomo Nasu. Yasutomo Nasu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kawada, Tatsushi, Takafumi Yanagisawa, Paweł Rajwa, et al.. (2024). The Prognostic Value of Tumor Infiltrating Lymphocytes After Radical Cystectomy for Bladder Cancer: A Systematic Review and Meta-Analysis. Clinical Genitourinary Cancer. 22(2). 535–543.e4. 6 indexed citations
2.
Matsumoto, Jun, Soichiro Ushio, Toshihiro Koyama, et al.. (2022). Significance of UGT1A6, UGT1A9, and UGT2B7 genetic variants and their mRNA expression in the clinical outcome of renal cell carcinoma. Molecular and Cellular Biochemistry. 478(8). 1779–1790. 1 indexed citations
3.
Araki, Motoo, Koichiro Wada, Yuki Maruyama, et al.. (2021). Feasible kidney donation with living marginal donors, including diabetes mellitus. Immunity Inflammation and Disease. 9(3). 1061–1068. 4 indexed citations
4.
Yamaguchi, Teruhide, Eriko Uchida, Takashi Okada, et al.. (2020). Aspects of Gene Therapy Products Using Current Genome-Editing Technology in Japan. Human Gene Therapy. 31(19-20). 1043–1053. 10 indexed citations
5.
Sadahira, Takuya, Yuki Maruyama, Yosuke Mitsui, et al.. (2020). Comparison of inflammation-based prognostic scores as predictors of survival outcomes in patients with germ cell tumors. Investigative and Clinical Urology. 62(1). 47–47. 6 indexed citations
6.
Matsubara, Takehiro, Shuta Tomida, Junichi Soh, et al.. (2017). Effects of Cold Ischemia on RNA Stability and Quality of Lung Tissues Based on Standard PREanalytical Code Categorization. Biopreservation and Biobanking. 15(5). 484–486. 1 indexed citations
7.
Watanabe, Masami, Takuya Sadahira, Yuichi Ariyoshi, et al.. (2017). Overexpression of REIC/Dkk-3 suppresses the expression of CD147 and inhibits the proliferation of human bladder cancer cells. Oncology Letters. 14(3). 3223–3228. 5 indexed citations
8.
Yamada, Hiroshi, et al.. (2016). Dynamin2 GTPase contributes to invadopodia formation in invasive bladder cancer cells. Biochemical and Biophysical Research Communications. 480(3). 409–414. 21 indexed citations
9.
Noguchi, Masanori, Kazumasa Matsumoto, Hirotsugu Uemura, et al.. (2015). An Open-Label, Randomized Phase II Trial of Personalized Peptide Vaccination in Patients with Bladder Cancer that Progressed after Platinum-Based Chemotherapy. Clinical Cancer Research. 22(1). 54–60. 49 indexed citations
10.
Hayashi, Tatsuro, Hiroaki Asano, Shinichi Toyooka, et al.. (2012). DNA methylation status of REIC/Dkk-3 gene in human malignancies. Journal of Cancer Research and Clinical Oncology. 138(5). 799–809. 25 indexed citations
11.
Kubo, Takafumi, Shinichi Toyooka, Kazunori Tsukuda, et al.. (2011). Epigenetic Silencing of MicroRNA-34b/c Plays an Important Role in the Pathogenesis of Malignant Pleural Mesothelioma. Clinical Cancer Research. 17(15). 4965–4974. 92 indexed citations
12.
Huang, Peng, Jie Chen, Lei Wang, et al.. (2011). Implications of transcriptional factor, OCT-4, in human bladder malignancy and tumor recurrence. Medical Oncology. 29(2). 829–834. 44 indexed citations
13.
Ochiai, Kazuhiko, Masami Watanabe, Peng Huang, et al.. (2011). Tumor suppressor REIC/Dkk-3 interacts with the dynein light chain, Tctex-1. Biochemical and Biophysical Research Communications. 412(2). 391–395. 22 indexed citations
14.
Uemura, Motohide, Seijiro Honma, Suyoun Chung, et al.. (2010). 5αDH‐DOC (5α‐dihydro‐deoxycorticosterone) activates androgen receptor in castration‐resistant prostate cancer. Cancer Science. 101(8). 1897–1904. 15 indexed citations
15.
Tanimoto, Ryuta, Fernando Abarzúa, Masakiyo Sakaguchi, et al.. (2007). REIC/Dkk-3 as a potential gene therapeutic agent against human testicular cancer. International Journal of Molecular Medicine. 19(3). 363–8. 56 indexed citations
16.
Kaku, Haruki, Tomoyasu Tsushima, Yasutomo Nasu, et al.. (2002). Combination chemotherapy with estramustine phosphate, ifosfamide and cis-platin in hormone-refractory prostate cancer. 64(4). 236–241. 1 indexed citations
17.
Tsushima, Tomoyasu, Takanori Murakami, Shin Ebara, et al.. (1998). Partial cystectomy in the treatment of invasive bladder cancer. 60(5). 397–401.
18.
Nasu, Yasutomo. (1994). Visual Laser Assisted Prostatectomy (VLAP) Using Urolase Right Angle Fiber -Intial Experiences in Japan-. 7(2). 185–189.
19.
Tsushima, Tomoyasu, et al.. (1993). Postoperative adjuvant chemotherapy by early intravesical instillations of epirubicin for the treatment of superficial bladder cancer. 55(1). 43–45. 1 indexed citations
20.
Tsushima, Tomoyasu, et al.. (1992). Bladder-sparing approach for invasive bladder cancer - Preoperative intra-arterial infusion chemotherapy and bladder preservation. 54(4). 441–445. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joseph E. Italiano Breakdown of academic impact, for papers by Ricardo D. Coletta Breakdown of academic impact, for papers by Bernd Wullich Breakdown of academic impact, for papers by Jiří Bártek Breakdown of academic impact, for papers by Jerry Ware Breakdown of academic impact, for papers by Márcio F. Chedid Breakdown of academic impact, for papers by Henrik Alfthan Breakdown of academic impact, for papers by Dietrich von Schweinitz Breakdown of academic impact, for papers by Arinobu Tojo Breakdown of academic impact, for papers by Fabien Calvo
Rankless by CCL
2026